Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it ...

May 12 (Reuters) - Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised ...

Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising ...

Isomorphic Labs, which hasn’t yet disclosed a molecule or reached the clinic, breaks the recent trend of investors putting ...

What do weapons and drug discovery have in common? Over the last 24 hours, billions of dollars and a lead investor.

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. LONDON, May 12, 2026 /CNW/ -- Isomorphic ...

The proceeds will be used to accelerate Isomorphic Labs’ pipeline of therapeutic programmes and further develop its IsoDDE AI ...

Alphabet Inc.’s Isomorphic Labs raised $2.1 billion in its second round of outside capital, with new support from sovereign wealth funds, as it seeks to make artificial intelligence-designed drugs a ...

Advanced discussions are underway to raise more than $2B for Isomorphic Labs, an AI-driven drug discovery firm spun out of Alphabet's (GOOG) Google DeepMind, as part of a new funding round, Bloomberg ...

Isomorphic, which is building a unified drug discovery product based on artificial intelligence (AI), is the third company to ...

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...

In 2024, DeepMind and Isomorphic Labs released a significantly improved successor to the model. AlphaFold 3 delivers a more ...